Literature DB >> 24592090

Assessment of early decline in the percentage of β-hCG values between days 0 and 4 after methotrexate therapy in ectopic pregnancy for the prediction of treatment success.

Ebru Celik1, Ilgın Türkçüoğlu1, Abdullah Karaer1, Pinar Kırıcı1, Sevil Eraslan1.   

Abstract

OBJECTIVE: To evaluate percentage changes in serum beta-human chorionic gonadotropin (β-hCG) values between days 0-1, 0-4 and 0-7 as an indicator of methotrexate therapy success in extra-uterine pregnancies.
MATERIAL AND METHODS: Women with ectopic pregnancy treated with single-dose methotrexate therapy between January 2011 and August 2012 were assessed. Recorded data were reviewed electronically from patient files. All women (n=93) with an ectopic pregnancy treated medically with intramuscular methotrexate (50 mg/m(2)) were included. The percentage changes in serum β-hCG levels from day 0 to 1, day 0 to 4 and day 0 to 7 were calculated for each case.
RESULTS: The median β-hCG values decreased between days 0 and 4 by 55.8%, and 89.6% of these cases were treatment successes. The median initial serum β-hCG values were lower in women with successful treatment, but this was not statistically significant (p=0.11).
CONCLUSION: A decline in serum β-hCG values between days 0 and 4 appears to be the best predictor. It would be beneficial to determine whether a woman with an ectopic pregnancy treated with single-dose methotrexate administration will be treated successfully.

Entities:  

Keywords:  Ectopic pregnancy; human chorionic gonadotrophin; methotrexate

Year:  2013        PMID: 24592090      PMCID: PMC3928408          DOI: 10.5152/jtgga.2013.50133

Source DB:  PubMed          Journal:  J Turk Ger Gynecol Assoc        ISSN: 1309-0380


  22 in total

Review 1.  The nonsurgical management of ectopic pregnancy.

Authors:  Emma Kirk; Tom Bourne
Journal:  Curr Opin Obstet Gynecol       Date:  2006-12       Impact factor: 1.927

2.  The medical management of ectopic pregnancy: a meta-analysis comparing "single dose" and "multidose" regimens.

Authors:  Kurt T Barnhart; Gabriella Gosman; Rachel Ashby; Mary Sammel
Journal:  Obstet Gynecol       Date:  2003-04       Impact factor: 7.661

3.  Presence of a yolk sac on transvaginal sonography is the most reliable predictor of single-dose methotrexate treatment failure in ectopic pregnancy.

Authors:  Sarah Bixby; Richard Tello; Ewa Kuligowska
Journal:  J Ultrasound Med       Date:  2005-05       Impact factor: 2.153

4.  Transvaginal sonography as the ultimate diagnostic tool for the management of ectopic pregnancy: experience with 840 cases.

Authors:  E Shalev; I Yarom; M Bustan; E Weiner; I Ben-Shlomo
Journal:  Fertil Steril       Date:  1998-01       Impact factor: 7.329

5.  Single-dose methotrexate for the treatment of ectopic pregnancy: Northwestern Memorial Hospital three-year experience.

Authors:  C S Stika; L Anderson; M C Frederiksen
Journal:  Am J Obstet Gynecol       Date:  1996-06       Impact factor: 8.661

6.  Characterizing ectopic pregnancies that rupture despite treatment with methotrexate.

Authors:  Paul S Dudley; Michael J Heard; Haleh Sangi-Haghpeykar; Sandra A Carson; John E Buster
Journal:  Fertil Steril       Date:  2004-11       Impact factor: 7.329

7.  Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies.

Authors:  G H Lipscomb; M L McCord; T G Stovall; G Huff; S G Portera; F W Ling
Journal:  N Engl J Med       Date:  1999-12-23       Impact factor: 91.245

8.  Are early human chorionic gonadotropin levels after methotrexate therapy a predictor of response in ectopic pregnancy?

Authors:  Quyen Nguyen; Martha Kapitz; Katheryne Downes; Celso Silva
Journal:  Am J Obstet Gynecol       Date:  2010-06       Impact factor: 8.661

9.  The optimal cutoff serum level of human chorionic gonadotropin for efficacy of methotrexate treatment in women with extrauterine pregnancy.

Authors:  Ron Sagiv; Abraham Debby; Hagit Feit; Bina Cohen-Sacher; Ran Keidar; Abraham Golan
Journal:  Int J Gynaecol Obstet       Date:  2011-11-17       Impact factor: 3.561

10.  Prognostic value of human chorionic gonadotropin changes after methotrexate injection for ectopic pregnancy.

Authors:  Aubert Agostini; Karina Blanc; Isabelle Ronda; Fanny Romain; Mariane Capelle; Bernard Blanc
Journal:  Fertil Steril       Date:  2007-04-06       Impact factor: 7.329

View more
  2 in total

1.  [Factors associated with the failure of medical treatment for ectopic pregnancy: case study conducted at the Yaoundé Gynaecology, Obstetrics and Pediatrics Hospital].

Authors:  Pascal Foumane; Esther Juliette Ngo Um Meka; Félix Essiben; Émeric Lionel Botsomogo; Julius Dohbit Sama; Isidore Tompeen; Etienne Belinga; Emile Mboudou
Journal:  Pan Afr Med J       Date:  2022-03-11

2.  Time to resolution of tubal ectopic pregnancy following methotrexate treatment: A retrospective cohort study.

Authors:  Marcus J Davenport; Anthea Lindquist; Fiona Brownfoot; Natasha Pritchard; Stephen Tong; Roxanne Hastie
Journal:  PLoS One       Date:  2022-05-24       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.